Key Market Overview:
Digital Therapeutics market size was valued at USD 4.4 Billion in 2021, registering a CAGR of 16.8% during the forecast period (2022-2030), and the market is projected to be worth USD 17.9 Billion by 2030.
The increased need of monitoring health vital especially in terms of obesity and diabetes is anticipated to boost the demand for digital therapeutics owing to the wide availability of the health tracking products. For instance, according to the World Health Organization, in 2020 around 38.3 million children that fall under the age of 5 years are expected to be obese or overweight globally. Thus, the high need of digital therapeutics for tracking of major health cues such as body weight, blood sugar levels and blood pressure levels is expected to boost the industry growth.
Moreover, the increased adoption of smartphones among population is estimated to drive the market growth owing to the high adoption of technological advancement such as digital therapeutics into the devices as health tracking software. For instance, as per the survey report conducted by Pew Research Center, the smartphone adoption rate among people of the U.S. was over 72.7% in 2020. Thus, the active company launches in terms of innovative products as digital therapeutics in the smartphones is anticipated to witness as significant growth during the forecast period. In the context of the region, North America is projected to contribute a substantial share to the industry growth owing to the growing public and private funding for the technological advancement in medical facilities coupled with the growing customer awareness in terms of digital therapeutics and established medical sector network such as the pharmaceutical and healthcare are estimated to boost the market growth in the North American region.
Market Dynamics:
Digital Therapeutics (DTx) is a recent technological advancement that helps in direct delivery of the medical interventions to the patients by using evidence-based and clinically assessed high-quality software. Such medical delivery facilitates the treatment, management and prevention of the broad spectrum of disorders and diseases. The DTx products are reviewed and certified by regulatory bodies to support the product claims of efficacy, risk, and intended use.
Driver:
The rising smartphone penetration among population coupled with the increased cost-effectiveness of digital health technology are the major factors that accelerate the digital therapeutics market statistics owing to the increased consumer awareness in terms of smart health tracking. Furthermore, the increased prevalence of chronic diseases due to inactive lifestyle especially among the geriatric population also fuels the market growth during the forecast period due to the surging usage of the clinical applications of the technology.
Restraint:
The high computational costs and security concerns related to the patient data restrict the large-scale usage of digital therapeutics in multiple application segments. Additionally, the shortage of technical professionals especially in the medical sector also hampers the market growth during the forecast period owing to the limited protocol regulations in terms of digital tools usage for patient data collection and management.
Opportunities:
The scope of exploring the unexplored areas of digital therapeutic applications are expected to provide lucrative opportunities for market growth during the forecast period owing to the augmented biomedical research initiatives for diseases such as chronic pain, neurocognitive disorders, epilepsy, autism spectrum disorder (ASD), insomnia and others.
COVID-19 Impact:
The digital therapeutics market has been positively impacted due to the COVID-19 pandemic in different parts of the world. The factors such as augmented usage of digital health alternatives combined with the increased regulatory initiatives in terms of ease of public health emergency are the major impacts of COVID-19 which supported market growth especially during the period of the pandemic. However, the shipments were impacted during the initial lockdown due to the closure of the manufacturing facility of such technology and disrupted supply chain which led to the decline. However, the circumstances have stabilized and as a result, it is determined that COVID-19’s overall impact on the industry is moderate. Post covid-19, there was a positive impact on market growth due to the growing emphasis on research and development of technology for enhanced treatment standardization.
Digital Therapeutics Report Coverage:
| Report Attributes | Report Details |
| Study Timeline | 2016-2030 |
| Market Size in 2030 (USD Billion) | 17.9 Billion |
| CAGR (2022-2030) | 16.8% |
| By Product Type | Software and Devices |
| By Application | Diabetes, Obesity, Cardiovascular Diseases (CVD), Substance Abuse, Central Nervous Diseases (CNS), Multiple Sulfatase Deficiency (MSD), Gastrointestinal Disorder (GID) |
| By Sales Channel | Business-to Consumer (Caregiver, Patient), Business-to-Business (Providers, Pharmaceuticals Employer) |
| By Geography | North America– (U.S., Canada, Mexico)
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe) Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific) Latin America- (Brazil, Argentina, Chile, Rest of Latin America) Middle East and Africa- (GCC, Turkey, Israel, and the Rest of MEA) |
| Key Players | Fitbit Health Solutions, Pear Therapeutics, Inc., 2MORROW, Inc., Medtronic Plc., Livongo Health, Inc., Omada Health, Inc., Resmed, Inc. (Propeller Health), Proteus Digital Health, Inc., Welldoc, Inc.,Voluntis, Inc., Canary Health Inc., Noom, Inc. |
Market Segmentation:
By Product Type
The product type segment is bifurcated into the software and devices. The software segment is anticipated to register the fastest CAGR growth during the forecast period. The factors such as enhanced patient-oriented medical interventions, rising development of digital health tracker apps combined with increased smartphone penetration among population in terms of growing digital health awareness are estimated to support the contribution of the software segment in digital therapeutics market growth. Also, the devices segment is estimated to contribute the largest share of the market growth owing to the increased adoption of health tracking devices such as smartwatches and armband health trackers coupled with the large availability of the products for augmented health management.
By Application
The application segment is categorized into diabetes, obesity, cardiovascular diseases (CVD), substance abuse, central nervous diseases (CNS), multiple sulfatase deficiency (MSD), and gastrointestinal disorder (GID). The diabetes segment registered the largest share over 28.6% to the industry growth during the forecast period. The factors such as improved analysis of the dietary and physical workout changes, continuous monitoring of the blood sugar levels and increased medical adherence support for controlled diabetic levels are anticipated to support the growth of the diabetes segment. Additionally, the CVDs, substance abuse and obesity segments are also anticipated to witness the significant growth during the projected period owing to the high adoption of digital therapeutics for controlled monitoring of patient behavioral changes in terms of mental and physical changes coupled with the continuous digital medical professional support for emergency help in case of uncontrolled health concerns, especially for substance abuse and CVD patients.
By Sales Channel
The end-user segment is divided into business-to consumer (caregiver, patient), business-to-business (providers, pharmaceuticals employer). The business-to consumer segment is anticipated to register the largest contribution to the digital therapeutics market share of over 33.2% during the forecast period. The factors such as the primary and largest customer base as patients, easy accessibility of the services as the cost effective solutions, and increased initiatives to boost the usage among population in terms of multiple healthcare applications and programs are estimated to support the business-to consumer segment growth. Furthermore, the business-to-business segment is also expected to witness the substantial growth in terms of volume owing to the improved scalability of the digital therapeutic solutions, enhanced reach to the wider customer base especially medical professional and trainers coupled with the increased emphasis on customer centric service provision such as improved customer support in health devices for continuous health tracking.
By Region
The regional segment includes Asia Pacific, Europe, North America, the Middle East, and Africa, Latin America. North America is anticipated to contribute the largest share to the market growth in 2021. The factors such as the high and first adoption of technological advancements in terms of healthcare, combined with the rising public and private spending on medical facilities and the large presence of the established market players are anticipated to fuel the market growth in the North American region.
Asia Pacific is also estimated to register the fastest growth in terms of value and volume during the forecast period owing to the rising expenditures on the research and development of technologically advanced alternatives in terms of cost effectiveness for large adoption, presence of large patient pool with increased demand for digital therapeutic solutions such as smartwatches for continuous health tracking, and enhanced medical infrastructure owing to the surging technical benefits of interventional and diagnostic purposes are estimated to fuel the market growth in the Asia Pacific region.
Digital Therapeutics Market Competitive Landscape:
The competitive landscape of the digital therapeutics industry has been examined in the report. Additionally, the detailed profiles of the major industry players is also assessed in terms of the surge in Research and Development (R&D), product innovations, application launches and company business strategies have augmented the growth of the sample preparation market. Key players in the market include-
- Fitbit Health Solutions
- Pear Therapeutics, Inc.
- 2MORROW, Inc.
- Medtronic Plc.
- Livongo Health, Inc.
- Omada Health, Inc.
- Resmed, Inc. (Propeller Health)
- Proteus Digital Health, Inc.
- Welldoc, Inc.,Voluntis, Inc.
- Canary Health Inc.
- Noom, Inc.
FAQ
How much is the Digital Therapeutics Market worth?
The Digital Therapeutics Market is worth USD 17.9 Billion by 2030.
Who are the major players operating in this industry?
Fitbit Health Solutions, Pear Therapeutics, Inc., 2MORROW, Inc., Medtronic Plc., Livongo Health, Inc., Omada Health, Inc., Resmed, Inc. (Propeller Health), Proteus Digital Health, Inc., Welldoc, Inc.,Voluntis, Inc., Canary Health Inc., Noom, Inc. are the major players operating in this industry.
Which region contributed the largest share of the market growth?
North America is anticipated to contribute the largest share to the market growth.
What is the main market-driving factor?
The rising smartphone penetration among population coupled with the increased cost-effectiveness of digital health technology.
Which is the leading product segment in this market?
The software Industry is the leading product segment in this market.
Table of Content
- Introduction
- Market Introduction
- Market Research Methodology
- Research Process
- Primary Research
- Secondary Research
- Data Collection Technique
- Data Sources
- Market Estimation Methodology
- Limitations of the Study
- Product Picture of Digital Therapeutics
- Global Digital Therapeutics Market: Classification
- Geographic Scope
- Years Considered for the Study
- Research Methodology in brief
- Parent Market Overview
- Overall Digital Therapeutics Market Regional Demand
- Research Programs/Design
- Market Breakdown and Data Triangulation Approach
- Data Source
- Secondary Sources
- Primary Sources
- Primary Interviews
- Average primary breakdown ratio
- Market Dynamics
- Drivers
- Drivers
- Restraints
- Restraints
- Opportunity
- Impact forces on market dynamics
- Impact forces during the forecast years
- Industry Value Chain
- Upstream analysis
- Downstream analysis
- Distribution Channel
- Direct Channel
- Indirect Channel
- Potential Customers
- Manufacturing/Operational Cost Analysis
- Pricing Analysis by Region
- Key Technology Landscape
- Regulatory Analysis
- Porter’s Analysis
- Supplier Power
- Buyer Power
- Substitution Threat
- Threat from New Entry
- Competitive Rivalry
- PESTEL Analysis
- Political Factors
- Economic Factor
- Social Factors
- Technological Factor
- Environmental Factors
- Legal Factor
- Covid-19 impact on Global Economy
- Covid-19 impact on Digital Therapeutics demand
- Post-Covid Impact on Digital Therapeutics Market Demand
- Impact Analysis of the Russia-Ukraine Conflict
- Drivers
- Global Digital Therapeutics Market Segmentation, by Revenue (USD Billion), (2022-2030)
- By Product
- Holographic Display
- Microscope
- Software
- Others
- By Application
- Medical Imaging
- Medical Education
- Biomedical Research
- Others
- By End Use
- Academic Centers
- Pharmaceutical & Biotechnology Companies
- Hospitals & Clinics
- Research Laboratories
- By Product
- Global Digital Therapeutics Market Overview, By Region
- North America Digital Therapeutics Market Revenue (USD Billion), by Countries, (2022-2030)
- US
- By Product
- By Application
- By End Use
- Canada
- Mexico
- US
- Europe Digital Therapeutics Market Revenue (USD Billion), by Countries, (2022-2030)
- France
- UK
- Spain
- Russia
- Italy
- BENELUX
- Asia Pacific Digital Therapeutics Market Revenue (USD Billion), by Countries, (2022-2030)
- China
- Japan
- Australia
- South Korea
- India
- ASEAN
- North America Digital Therapeutics Market Revenue (USD Billion), by Countries, (2022-2030)
- Latin America Digital Therapeutics Market Revenue (USD Billion), by Countries, (2022-2030)
- Brazil
- Argentina
- Chile
- Middle East and Africa Digital Therapeutics Market Revenue (USD Billion), by Countries, (2022-2030)
- GCC
- Turkey
- South Africa
- Global Digital Therapeutics Market Revenue: Competitive Analysis, 2021
- Key strategies by players
- Revenue (USD Billion and %), By manufacturers, 2021
- Player Positioning by Market Players, 2021
- Competitive Analysis
- Fitbit Health Solutions
- Business Overview
- Business Financials (USD Billion)
- Product Category, Type, and Specification
- Main Business/Business Overview
- Geographical Analysis
- Recent Development
- Swot Analysis
- Pear Therapeutics, Inc.
- 2MORROW, Inc.
- Medtronic Plc.
- Livongo Health, Inc.
- Omada Health, Inc.
- Resmed, Inc. (Propeller Health)
- Proteus Digital Health, Inc.
- Welldoc, Inc.,Voluntis, Inc.
- Canary Health Inc.
- Noom, Inc.
- Fitbit Health Solutions
- Market Research Findings & Conclusion
Disclaimer
Research Methodology
The Market Research Community offers numerous solutions and its full addition in the research methods to be skilled at each step. We use wide-ranging resources to produce the best outcome for our customers. The achievement of a research development is completely reliant on the research methods implemented by the company. We always faithful to our clients to find opportunities by examining the global market and offering economic insights.Market Research Community are proud of our widespread coverage that encompasses the understanding of numerous major industry domains. Company offers consistency in our research report, we also offers on the part of the analysis of forecast across a range of coverage geographies and coverage. The research teams carry out primary and secondary research to carry out and design the data collection methods.